Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Shimizu, Hiroaki
[Clear All Filters]
2021
Yagi Y
,
Kanemasa Y
,
Ohigashi A
,
Morita Y
,
Tamura T
,
Nakamura S
,
Otsuka Y
,
Kishida Y
,
Kageyama A
,
Shimizuguchi T
, et al.
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report.
Medicine (Baltimore). 2021;100(44):e27733.
PubMed
Google Scholar
Yasuda S
,
Najima Y
,
Konishi T
,
Yamada Y
,
Nagata A
,
Takezaki T
,
Kaito S
,
Kurosawa S
,
Sakaguchi M
,
Harada K
, et al.
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
Leuk Res. 2021;108:106627.
PubMed
Google Scholar
2020
Akahoshi Y
,
Kimura S-I
,
Inamoto Y
,
Seo S
,
Muranushi H
,
Shimizu H
,
Ozawa Y
,
Tanaka M
,
Uchida N
,
Kanda Y
, et al.
Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality.
Clin Infect Dis. 2020.
PubMed
Google Scholar
Kikuchi T
,
Mori T
,
Ohwada C
,
Onoda M
,
Shimizu H
,
Yokoyama H
,
Onizuka M
,
Koda Y
,
Kato J
,
Takeda Y
, et al.
Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine.
Int J Hematol. 2020.
PubMed
Google Scholar
2019
Kako S
,
Kanda Y
,
Onizuka M
,
Aotsuka N
,
Usuki K
,
Tachibana T
,
Kobayashi T
,
Kato J
,
Yano S
,
Shimizu H
, et al.
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: a KSGCT prospective study.
Am J Hematol. 2019.
PubMed
Google Scholar
Ohwada C
,
Sakaida E
,
Igarashi A
,
Kobayashi T
,
Doki N
,
Mori T
,
Kato J
,
Koda Y
,
Kanamori H
,
Tanaka M
, et al.
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
2018
Akahoshi Y
,
Mizuta S
,
Shimizu H
,
Uchida N
,
Fukuda T
,
Kanamori H
,
Onizuka M
,
Ozawa Y
,
Ohashi K
,
Ohta S
, et al.
Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era.
Biol Blood Marrow Transplant. 2018.
PubMed
Google Scholar